György Haskó mainly focuses on Adenosine, Receptor, Immunology, Purinergic signalling and Inflammation. His Adenosine research includes themes of Proinflammatory cytokine, Nucleoside, Adenosine receptor and Cell biology. His Receptor study is concerned with Internal medicine in general.
His Immunology study focuses on Immune system in particular. His work is dedicated to discovering how Purinergic signalling, Adenosine A3 receptor are connected with Adenosine A2B receptor and Macrophage and other disciplines. His Inflammation research focuses on Pharmacology and how it connects with Nitric oxide, Adenosine A2A receptor and Enzyme activator.
The scientist’s investigation covers issues in Adenosine, Inflammation, Internal medicine, Pharmacology and Endocrinology. His Adenosine research incorporates elements of Adenosine A3 receptor, Adenosine receptor, Receptor, Molecular biology and Cell biology. His Adenosine A3 receptor research incorporates themes from Adenosine A1 receptor, Purinergic signalling and Stimulation.
The concepts of his Cell biology study are interwoven with issues in Proinflammatory cytokine and Interleukin 10. His Inflammation research entails a greater understanding of Immunology. As a part of the same scientific family, György Haskó mostly works in the field of Internal medicine, focusing on PARP inhibitor and, on occasion, Cardiac function curve and Endothelial dysfunction.
György Haskó mostly deals with Adenosine, Internal medicine, Adenosine receptor, Inflammation and Endocrinology. His research integrates issues of Adenosine A3 receptor, Immune system, Receptor, Purinergic signalling and Cell biology in his study of Adenosine. His Immune system research is under the purview of Immunology.
His research investigates the connection between Purinergic signalling and topics such as Adenosine A2B receptor that intersect with issues in Adenosine A1 receptor. Many of his research projects under Internal medicine are closely connected to Oxidopamine with Oxidopamine, tying the diverse disciplines of science together. Adenosine receptor and Pharmacology are commonly linked in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
György Haskó;Joel Linden;Bruce Cronstein;Pál Pacher.
Nature Reviews Drug Discovery (2006)
Adenosine: an endogenous regulator of innate immunity
György Haskó;György Haskó;Bruce N. Cronstein.
Trends in Immunology (2004)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov;Pál Pacher;Peter M. Schmidt;György Haskó.
Nature Reviews Drug Discovery (2006)
CD39 and CD73 in immunity and inflammation
Luca Antonioli;Pál Pacher;E. Sylvester Vizi;E. Sylvester Vizi;György Haskó.
Trends in Molecular Medicine (2013)
Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms
György Haskó;David G. Kuhel;Jiang Fan Chen;Michael A. Schwarzschild.
The FASEB Journal (2000)
Immunity, inflammation and cancer: a leading role for adenosine
Luca Antonioli;Corrado Blandizzi;Pál Pacher;György Haskó;György Haskó.
Nature Reviews Cancer (2013)
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy.
Partha Mukhopadhyay;Mohanraj Rajesh;György Haskó;Brian J Hawkins.
Nature Protocols (2007)
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Partha Mukhopadhyay;Mohanraj Rajesh;Sándor Bátkai;Yoshihiro Kashiwaya.
American Journal of Physiology-heart and Circulatory Physiology (2009)
Simple quantitative detection of mitochondrial superoxide production in live cells
Partha Mukhopadhyay;Mohanraj Rajesh;Kashiwaya Yoshihiro;György Haskó.
Biochemical and Biophysical Research Communications (2007)
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Mohanraj Rajesh;Partha Mukhopadhyay;Sándor Bátkai;Vivek Patel.
Journal of the American College of Cardiology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: